431 related articles for article (PubMed ID: 22552868)
1. Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.
Crawford GB; Brindis RG; Krucoff MW; Mansalis BP; Carroll JD
Catheter Cardiovasc Interv; 2012 Aug; 80(2):157-67. PubMed ID: 22552868
[TBL] [Abstract][Full Text] [Related]
2. Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe?
Diab K; Kenny D; Hijazi ZM
Catheter Cardiovasc Interv; 2012 Aug; 80(2):168-74. PubMed ID: 22718680
[No Abstract] [Full Text] [Related]
3. A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.
Hill KD; Lodge AJ; Forsha D; Fleming GA; Green AS; Rhodes JF
Catheter Cardiovasc Interv; 2013 Mar; 81(4):654-9. PubMed ID: 22639441
[TBL] [Abstract][Full Text] [Related]
4. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk.
Amin Z; Hijazi ZM; Bass JL; Cheatham JP; Hellenbrand WE; Kleinman CS
Catheter Cardiovasc Interv; 2004 Dec; 63(4):496-502. PubMed ID: 15558755
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement.
Amin Z
Catheter Cardiovasc Interv; 2014 Jan; 83(1):84-92. PubMed ID: 24038861
[TBL] [Abstract][Full Text] [Related]
6. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
[TBL] [Abstract][Full Text] [Related]
7. [Factors influencing the choice of atrial septal occluder for transcatheter closure of secundum atrial septal defects].
Zhang YS; Lan BD; Li H; He XM; Dai ZX; Wang HC; Zhang J; Li J; DU YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):981-5. PubMed ID: 20137320
[TBL] [Abstract][Full Text] [Related]
8. Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study.
McElhinney DB; Quartermain MD; Kenny D; Alboliras E; Amin Z
Circulation; 2016 May; 133(18):1738-46. PubMed ID: 27002094
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of Cardi-O-Fix septal occluder versus Amplatzer septal occluder in percutaneous closure of secundum atrial septal defects.
Saritas T; Kaya MG; Lam YY; Erdem A; Akdeniz C; Demir F; Erol N; Demir H; Celebi A
Catheter Cardiovasc Interv; 2013 Jul; 82(1):116-21. PubMed ID: 21805616
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.
Godart F; Houeijeh A; Recher M; Francart C; Polge AS; Richardson M; Cajot MA; Duhamel A
Arch Cardiovasc Dis; 2015 Jan; 108(1):57-63. PubMed ID: 25453168
[TBL] [Abstract][Full Text] [Related]
11. Very late erosion of Amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement.
Roberts WT; Parmar J; Rajathurai T
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E592-4. PubMed ID: 23172721
[TBL] [Abstract][Full Text] [Related]
12. Growth of the atrial septum after Amplatzer device closure of atrial septal defects in young children.
Gossett JG; Mansfield L; Acevedo J; Lay AS; Rychlik K; Wax DF
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1041-7. PubMed ID: 26013563
[TBL] [Abstract][Full Text] [Related]
13. Surgical perspective of percutaneous device closure of atrial septal defect.
Thingnam SKS; Mahajan S; Kumar V
Asian Cardiovasc Thorac Ann; 2018 Jun; 26(5):343-346. PubMed ID: 29719981
[TBL] [Abstract][Full Text] [Related]
14. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder.
Divekar A; Gaamangwe T; Shaikh N; Raabe M; Ducas J
J Am Coll Cardiol; 2005 Apr; 45(8):1213-8. PubMed ID: 15837251
[TBL] [Abstract][Full Text] [Related]
15. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect.
Sommer RJ; Love BA; Paolillo JA; Gray RG; Goldstein BH; Morgan GJ; Gillespie MJ;
Catheter Cardiovasc Interv; 2020 Jun; 95(7):1285-1295. PubMed ID: 31943749
[TBL] [Abstract][Full Text] [Related]
16. Late erosion of Amplatzer septal occluder device resulting in cardiac tamponade.
Tchantchaleishvili V; Melvin AL; Ling FS; Knight PA
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1074-6. PubMed ID: 25183740
[TBL] [Abstract][Full Text] [Related]
17. First experiences with the GORE(®) Septal Occluder in children and adults with atrial septal defects.
Nyboe C; Hjortdal VE; Nielsen-Kudsk JE
Catheter Cardiovasc Interv; 2013 Nov; 82(6):929-34. PubMed ID: 23404677
[TBL] [Abstract][Full Text] [Related]
18. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE® septal occluder.
Grohmann J; Höhn R; Fleck T; Schmoor C; Stiller B
Catheter Cardiovasc Interv; 2014 Nov; 84(6):E51-7. PubMed ID: 24664494
[TBL] [Abstract][Full Text] [Related]
20. Confidence in ASD occluder devices is eroding.
Lange RA
Catheter Cardiovasc Interv; 2012 Aug; 80(2):175-6. PubMed ID: 22825983
[No Abstract] [Full Text] [Related]
[Next] [New Search]
